Press release
Plant Peptides Market Set to Triple, Crossing USD 2.66 Billion by 2035, Driven by Therapeutic and Bioactive Innovations
Plant Peptides Market
Get Exclusive Access To Data Tables, Market Sizing Dashboards, And Analyst Insights. Request Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-26252
A Decade of Steady and Accelerated Growth
Market expansion from 2025 to 2030 is expected to contribute USD 656.4 million, increasing market size to nearly USD 1,506.4 million, as adoption strengthens across nutraceuticals and cosmetics. Demand for high-purity powders and encapsulated formats is set to escalate as consumers shift toward clean-label, functional, and clinically supported bioactives.
The subsequent phase, from 2030 to 2035, is forecast to drive 64% of the incremental growth, with an addition of USD 1,157.2 million. This phase will witness large-scale penetration into pharmaceutical-grade formulations supported by controlled-release technologies, clinical validation, and regulatory approvals.
Market Leaders and Competitive Shifts
Historically, large players such as Roquette, Kerry Group plc, and Ingredion Inc. commanded nearly half of the market using robust supply chain infrastructure. However, competitive dynamics are shifting toward science-backed peptide ecosystems. Innovators like Burcon NutraScience, Axiom Foods, and cosmetic peptide specialists such as Symrise AG and Givaudan are strengthening their presence with advanced bioactive peptide solutions.
Why the Market is Growing
Demand is driven by the convergence of natural wellness, functional nutrition, pharmaceutical innovation, and plant-derived cosmetic actives. Growth catalysts include:
• Rising clean-label nutrition and preventive health awareness
• Clinically validated peptide benefits for immunity, metabolic regulation, and cardiovascular support
• Advancements in enzyme hydrolysis, encapsulation, and bioavailability enhancement
• Rising preference for natural anti-aging and skin barrier-protective formulations
• Expansion of contract manufacturing in emerging markets enabling cost-effective scalability
Form, Source, and Peptide Type Insights
Leading Segment in 2025: Powder (54.2%)
Powder formulations dominate due to stability, cost efficiency, and wide applicability in sports nutrition, fortified foods, beverages, and dietary supplements. Although liquid concentrates and encapsulated formats are gaining ground, powders are forecast to retain leadership throughout the next decade.
Top Source: Soy (28.3% Revenue Share in 2025)
Soy continues to lead due to strong infrastructure, affordability, nutritional profile, and scalability across both mass-market and premium applications. Pea and rice sources are gaining favor due to non-allergen positioning and rising demand for clean-label protein bases.
Peptide Type Leadership: Nutritional Peptides (41.7%)
Nutritional peptides dominate in terms of market value, owing to affordability, digestibility, and mass-market applicability. Bioactive peptides are projected to scale faster as scientific validation strengthens their role in targeted therapies.
Regional Market Outlook
Emerging economies are positioned at the forefront of expansion. Key country CAGRs include:
• India: 13.4% (Fastest-growing globally)
• Brazil: 12.6%
• United Kingdom: 12.2%
• China: 11.8%
In the United States, the market will grow from USD 187.7 million in 2025 to USD 533.4 million by 2035, driven by nutraceuticals, cosmeceuticals, and the expanding role of therapeutic peptides. Europe's leadership remains aligned with regulatory-driven safety standards, with Germany and France championing clinical-grade adoption.
Key Industry Developments
• Symrise (June 2025): Launched SymLash® XTreme, a liquid lipopeptide-troxerutin complex designed for eyelash density improvement, accelerating peptide penetration in cosmetics.
• Symrise 2024 Financial Update: The company reported 11.5% organic growth in its Taste, Nutrition & Health division, fueled by bioactives and botanical peptides.
Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates - https://www.futuremarketinsights.com/reports/plant-peptides-market
Future Outlook
The next decade will witness a transition from commodity proteins to therapeutic and clinically proven peptide ecosystems, shaped by sustainability credentials, advanced delivery systems, and cross-industry partnerships. Bioefficacy-driven innovation is expected to make plant peptides indispensable across global food, pharma, and cosmetic value chains.
Why FMI: https://www.futuremarketinsights.com/why-fmi
Browse Related Insights
Peptide Supplements Market: https://www.futuremarketinsights.com/reports/peptide-supplements-market
Collagen Peptide Market: https://www.futuremarketinsights.com/reports/collagen-peptide-market
Marine Peptide Market: https://www.futuremarketinsights.com/reports/marine-peptide-market
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Plant Peptides Market Set to Triple, Crossing USD 2.66 Billion by 2035, Driven by Therapeutic and Bioactive Innovations here
News-ID: 4311366 • Views: …
More Releases from Future Market Insights
Sea Enzyme Products Market Poised to Reach USD 263.9 Million by 2035, Driven by …
The global Sea Enzyme Products Market is set to expand from USD 140.6 million in 2025 to USD 263.9 million by 2035, reflecting a robust absolute increase of USD 123.3 million over ten years. With a projected CAGR of 6.5%, the industry will experience a 1.9X market expansion, driven by rising adoption of bio-based enzymes across food processing, nutraceuticals, pharmaceuticals, and industrial biocatalysis.
To Explore Detailed Market Data, Segment-Wise Forecasts, and…
Marine Protein Hydrolysate Market Set to Reach USD 454.6 Million by 2035, Driven …
The global marine protein hydrolysate market is expected to grow from USD 298.4 million in 2025 to USD 454.6 million by 2035, at a CAGR of 4.3%, creating an absolute dollar opportunity of USD 156.2 million. Market expansion is propelled by growing applications in dietary supplements, functional foods, animal feed, aquaculture, and cosmetics, where marine proteins provide bioactive peptides with high digestibility and nutritional benefits.
The market is witnessing a two-phase…
Antimicrobial Feed Additives Market Reaching USD 6.5 Billion by 2035 Amid Antibi …
The Antimicrobial Feed Additives Market is projected to expand from USD 3,640.0 million in 2025 to USD 6,515.9 million by 2035, marking an impressive 79% growth. The market is expected to nearly double over the decade with a 6.0% CAGR, fueled by rising consumer demand for antibiotic-free animal products, regulatory pressures, and innovations in acidifiers, probiotics, and phytogenic solutions.
Explore trends before investing - request a sample report today! https://www.futuremarketinsights.com/reports/sample/rep-gb-26556
Market Growth…
Global Enzymes Market Projected to Grow Steadily at 6.8% CAGR, Hitting USD 29.7 …
The global enzymes market is estimated at USD 15.4 billion in 2025 and is projected to reach USD 29.7 billion by 2035, expanding at a CAGR of 6.8%. Demand continues to accelerate as manufacturers adopt enzymes to enhance productivity under mild conditions while reducing energy usage and chemical dependency. Food and beverage producers remain the largest buyers, especially in bakery, dairy, and brewing operations.
In healthcare applications, diagnostic tools and therapeutic…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
